Calls
2
Kiran Mazumdar Shaw
Founder & Chairperson, Biocon
Win Rate
0.0%
return
-6.1%
Ticker
Side
Mentions
First Call
Call Price
P&L
Thesis
Theme
Source
Long
Aug 21
$49.55
-3.1%
India should embed biotech sovereignty in AI by owning its biological data and knowledge so it can trade as an equal partner; India has the talent, developing infrastructure and strategic opportunity to be among the handful of countries between the US and China in biotech/AI.
Equity Indexes
Long
Jun 16
$418.00
-9.1%
Biocon has no reliance on Chinese supply chains; India's biotech talent and science provide an edge, and the company is well positioned to benefit from the push for biotech sovereignty.
Pharma & Biotech
Showing 2 of 2 calls · sorted by mentions
Choose a mentions count to open ticker posts.
Kiran Mazumdar Shaw has 2 trade ideas tracked on Buzzberg across 2 tickers since June 2026. Most covered: BIOCON.NS, INDA.
Historical call returns are modeled from recorded ideas and stored prices, not actual brokerage portfolio returns. Check the evaluated call set and horizon; past results do not establish future prediction accuracy. Explore our data and methodology
